BioSignals

BioCrossroads

BioSignals, powered by BioCrossroads, brings you inside the engine room of Indiana’s life sciences economy, where big ideas become real solutions and partnerships fuel progress. Host Vince Wong connects with C-suite leaders, scientific innovators, startup founders, and policy makers who are moving Indiana forward across biopharma, medical devices, diagnostics, health systems, and more. Each episode delivers candid insight into the trends, challenges, and opportunities shaping our sector, from advanced manufacturing and talent development to breakthrough research and investment strategy.

  1. 3d ago

    Ep. 14: Moving Beyond the Lab with David Rosenberg

    Indiana has built a global reputation for life sciences—one grounded in world-class companies, our historical strength in manufacturing and our world-class research institutions. But the next chapter of that story is about more than what Indiana can make. It’s about what Indiana ca invent, commercialize and build. That starts with the discoveries happening inside our universities, and the people and organizations that can help turn those discoveries into companies, technologies and real-world impact. On today’s episode of BioSignals, we’re exploring that journey with David Rosenberg of Indiana University. David leads IU LAB, an initiative focused on helping promising research and technologies move beyond the lab and toward commercialization. He’s also CEO of IU INC, which is designed to help build and accelerate the next generation of companies emerging from IU’s research enterprise. We’ll talk about David’s own path into this work, how IU identifies research with commercial potential, and what it takes to bridge the sometimes very different worlds of academic science and entrepreneurship. We’ll also zoom out to the bigger opportunity for Indiana. How do we keep companies created around Indiana research here and help them grow? How can universities, investors, entrepreneurs, companies and organizations like BioCrossroads work together more effectively? And what would it take for Indiana to become known not just for making life sciences products, but for inventing the companies behind them? This conversation was recorded in August 2026

    Ep. 14: Moving Beyond the Lab with David Rosenberg
  2. Nov 4

    Ep. 13: The Next Generation of Cancer Therapies with Dowdy Jackson, PhD

    Across the biotechnology industry, researchers are developing new ways to target cancer more precisely, delivering powerful therapies directly to tumor cells while working to limit the impact on healthy tissue. One promising approach is antibody-drug conjugates, which combine the targeting capabilities of antibodies with potent cancer fighting medicines. But turning that science into a safe and effective treatment requires years of research, rigorous testing and a deep understanding of tumor biology. Our guest today is Dr. Dowdy Jackson, Chief Scientific Officer of Antigenix Therapeutics, a biotechnology company developing antibody-based therapies for aggressive cancers. Dowdy brings more than 25 years of experience in pharmaceutical and biotechnology drug development, with expertise spanning antibody-drug conjugates, targeted therapies and other innovative approaches to treating cancer. Throughout his career, he has helped advance drug candidates from early discovery toward clinical development, including work on therapies that have gone on to receive FDA approval. Today, he is applying that experience to help advance Antigenix Therapeutics’ next generation of cancer treatments, with a focus on addressing diseases where patients still have significant unmet medical needs. So, as advances in biotechnology create new possibilities for precision oncology, what will it take to make the next generation of cancer therapies more effective—and how do we bridge the gap between promising science in the laboratory and meaningful outcomes for patients?

    Ep. 13: The Next Generation of Cancer Therapies with Dowdy Jackson, PhD
  3. Oct 9

    Ep. 12: Building the Healthcare System of the Future in the BioHeartland with Patrick McGill, MD

    Healthcare is changing. And it’s changing fast. AI and automation are reshaping how care is delivered. Workforce shortages and rising costs are challenging health systems to rethink how they operate. At the same time, advances in precision medicine, earlier disease detection and personalized care are creating new possibilities for patients. It’s a time of extreme challenges and, at the same time, great optimism. Few people are better positioned to see all of these forces coming together than our guest today, Dr. Patrick McGill, President and CEO of Community Health Network. Dr. McGill became CEO of Community in January 2026, after serving as the health system’s executive vice president and chief transformation officer. In that role, he led work across information technology, analytics, digital transformation, population health, personalized medicine, health equity and value-based care. His perspective is shaped by both medicine and technology. He is a practicing board-certified family medicine physician with an MBA focused on data analytics and a doctorate in healthcare administration, and he chairs the Indiana Health Information Exchange board. Today, Community Health Network has more than 200 sites of care and approximately 17,000 caregivers across Central Indiana, providing everything from primary and urgent care to advanced cancer, cardiovascular and behavioral health services. So, as one of Indiana’s largest healthcare organizations navigates a period of extraordinary transformation, what does the healthcare system of the future look like and how can technology and innovation help us build a healthier Indiana?

    Ep. 12: Building the Healthcare System of the Future in the BioHeartland with Patrick McGill, MD

Ratings & Reviews

5
out of 5
8 Ratings

About

BioSignals, powered by BioCrossroads, brings you inside the engine room of Indiana’s life sciences economy, where big ideas become real solutions and partnerships fuel progress. Host Vince Wong connects with C-suite leaders, scientific innovators, startup founders, and policy makers who are moving Indiana forward across biopharma, medical devices, diagnostics, health systems, and more. Each episode delivers candid insight into the trends, challenges, and opportunities shaping our sector, from advanced manufacturing and talent development to breakthrough research and investment strategy.

You Might Also Like